These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
631 related articles for article (PubMed ID: 32367746)
21. Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System: Celebrating the 20th Anniversary of the Discovery of ACE2. Gheblawi M; Wang K; Viveiros A; Nguyen Q; Zhong JC; Turner AJ; Raizada MK; Grant MB; Oudit GY Circ Res; 2020 May; 126(10):1456-1474. PubMed ID: 32264791 [TBL] [Abstract][Full Text] [Related]
22. Effects of Angiotensin II Receptor Blockers and ACE (Angiotensin-Converting Enzyme) Inhibitors on Virus Infection, Inflammatory Status, and Clinical Outcomes in Patients With COVID-19 and Hypertension: A Single-Center Retrospective Study. Yang G; Tan Z; Zhou L; Yang M; Peng L; Liu J; Cai J; Yang R; Han J; Huang Y; He S Hypertension; 2020 Jul; 76(1):51-58. PubMed ID: 32348166 [TBL] [Abstract][Full Text] [Related]
23. Cardiovascular Pharmacology in the Time of COVID-19: A Focus on Angiotensin-Converting Enzyme 2. Buckley LF; Cheng JWM; Desai A J Cardiovasc Pharmacol; 2020 Jun; 75(6):526-529. PubMed ID: 32301766 [TBL] [Abstract][Full Text] [Related]
24. [Renin Angiotensin Axis, Angiotensin Converting Enzyme 2 and Coronavirus]. Cano F; Gajardo M; Freundlich M Rev Chil Pediatr; 2020 Jun; 91(3):330-338. PubMed ID: 32730512 [TBL] [Abstract][Full Text] [Related]
25. Sex-Specific Modulation of Blood Pressure and the Renin-Angiotensin System by ACE (Angiotensin-Converting Enzyme) 2. Ji H; de Souza AMA; Bajaj B; Zheng W; Wu X; Speth RC; Sandberg K Hypertension; 2020 Aug; 76(2):478-487. PubMed ID: 32564694 [TBL] [Abstract][Full Text] [Related]
26. ACE2 and COVID-19 and the resulting ARDS. Zhang X; Li S; Niu S Postgrad Med J; 2020 Jul; 96(1137):403-407. PubMed ID: 32522846 [TBL] [Abstract][Full Text] [Related]
27. Spironolactone may provide protection from SARS-CoV-2: Targeting androgens, angiotensin converting enzyme 2 (ACE2), and renin-angiotensin-aldosterone system (RAAS). Cadegiani FA; Goren A; Wambier CG Med Hypotheses; 2020 Oct; 143():110112. PubMed ID: 32721806 [TBL] [Abstract][Full Text] [Related]
28. Interaction of SARS-CoV-2 and Other Coronavirus With ACE (Angiotensin-Converting Enzyme)-2 as Their Main Receptor: Therapeutic Implications. Davidson AM; Wysocki J; Batlle D Hypertension; 2020 Nov; 76(5):1339-1349. PubMed ID: 32851855 [TBL] [Abstract][Full Text] [Related]
29. Coronavirus Disease 2019 (COVID-19): Do Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Have a Biphasic Effect? Sommerstein R; Kochen MM; Messerli FH; Gräni C J Am Heart Assoc; 2020 Apr; 9(7):e016509. PubMed ID: 32233753 [No Abstract] [Full Text] [Related]
30. COVID-19 and renin-angiotensin system inhibition: role of angiotensin converting enzyme 2 (ACE2) - Is there any scientific evidence for controversy? Aleksova A; Ferro F; Gagno G; Cappelletto C; Santon D; Rossi M; Ippolito G; Zumla A; Beltrami AP; Sinagra G J Intern Med; 2020 Oct; 288(4):410-421. PubMed ID: 32459372 [TBL] [Abstract][Full Text] [Related]
31. Angiotensin-Converting Enzyme Gene Polymorphism and Severe Lung Injury in Patients with Coronavirus Disease 2019. Zheng H; Cao JJ Am J Pathol; 2020 Oct; 190(10):2013-2017. PubMed ID: 32735889 [TBL] [Abstract][Full Text] [Related]
32. Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19). Bourgonje AR; Abdulle AE; Timens W; Hillebrands JL; Navis GJ; Gordijn SJ; Bolling MC; Dijkstra G; Voors AA; Osterhaus AD; van der Voort PH; Mulder DJ; van Goor H J Pathol; 2020 Jul; 251(3):228-248. PubMed ID: 32418199 [TBL] [Abstract][Full Text] [Related]
33. The Cross-Talk between Age, Hypertension and Inflammation in COVID-19 Patients: Therapeutic Targets. Casucci G; Acanfora D; Incalzi RA Drugs Aging; 2020 Nov; 37(11):779-785. PubMed ID: 33084001 [TBL] [Abstract][Full Text] [Related]
34. The renin-angiotensin system - a therapeutic target in COVID-19? Sturrock BR; Milne KM; Chevassut TJ Clin Med (Lond); 2020 Jul; 20(4):e72-e75. PubMed ID: 32414711 [TBL] [Abstract][Full Text] [Related]
35. Considerations on the use of antihypertensive blockers of the renin-angiotensin system in adults and children in the face of the COVID-19 pandemic. Vázquez-Cornejo E Bol Med Hosp Infant Mex; 2020; 77(5):274-281. PubMed ID: 33064690 [TBL] [Abstract][Full Text] [Related]
36. Renin-angiotensin-aldosterone system and COVID-19 infection. Alexandre J; Cracowski JL; Richard V; Bouhanick B; Ann Endocrinol (Paris); 2020 Jun; 81(2-3):63-67. PubMed ID: 32370986 [TBL] [Abstract][Full Text] [Related]
37. Association of ACE2 receptor and ACEIs/ARBs with disease severity in COVID-19. Sinha S; Sehgal A; Sehgal R Drug Discov Ther; 2020; 14(4):161-170. PubMed ID: 32908071 [TBL] [Abstract][Full Text] [Related]
38. COVID-19 - Does This Disease Kill Due to Imbalance of the Renin Angiotensin System (RAS) Caused by Genetic and Gender Differences in the Response to Viral ACE 2 Attack? Arnold RH Heart Lung Circ; 2020 Jul; 29(7):964-972. PubMed ID: 32564908 [TBL] [Abstract][Full Text] [Related]
39. ACE2 the Janus-faced protein - from cardiovascular protection to severe acute respiratory syndrome-coronavirus and COVID-19. Touyz RM; Li H; Delles C Clin Sci (Lond); 2020 Apr; 134(7):747-750. PubMed ID: 32255491 [TBL] [Abstract][Full Text] [Related]
40. Good or bad: Application of RAAS inhibitors in COVID-19 patients with cardiovascular comorbidities. Wang JJ; Edin ML; Zeldin DC; Li C; Wang DW; Chen C Pharmacol Ther; 2020 Nov; 215():107628. PubMed ID: 32653530 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]